HCmed Innovations Co., Ltd. (TPEX:6934)

HCmed Innovations Statistics

Total Valuation

TPEX:6934 has a market cap or net worth of TWD 4.84 billion. The enterprise value is 4.67 billion.

Market Cap	4.84B
Enterprise Value	4.67B

Important Dates

The next estimated earnings date is Friday, April 10, 2026.

Earnings Date	Apr 10, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6934 has 32.72 million shares outstanding. The number of shares has increased by 6.80% in one year.

Current Share Class	32.72M
Shares Outstanding	32.72M
Shares Change (YoY)	+6.80%
Shares Change (QoQ)	+5.07%
Owned by Insiders (%)	28.87%
Owned by Institutions (%)	18.46%
Float	19.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.39
PB Ratio	18.15
P/TBV Ratio	18.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-38.14
EV / Sales	37.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-39.90

Financial Position

The company has a current ratio of 6.86, with a Debt / Equity ratio of 0.24.

Current Ratio	6.86
Quick Ratio	6.38
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	-0.54
Interest Coverage	-70.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-22.46%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6934 has paid 25.02 million in taxes.

Income Tax	25.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +100.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+100.68%
50-Day Moving Average	85.28
200-Day Moving Average	69.28
Relative Strength Index (RSI)	73.92
Average Volume (20 Days)	597,032

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6934 had revenue of TWD 122.94 million and -122.45 million in losses. Loss per share was -3.89.

Revenue	122.94M
Gross Profit	64.64M
Operating Income	-71.31M
Pretax Income	-97.43M
Net Income	-122.45M
EBITDA	-62.84M
EBIT	-71.31M
Loss Per Share	-3.89

Balance Sheet

The company has 235.88 million in cash and 63.67 million in debt, with a net cash position of 172.21 million or 5.26 per share.

Cash & Cash Equivalents	235.88M
Total Debt	63.67M
Net Cash	172.21M
Net Cash Per Share	5.26
Equity (Book Value)	266.79M
Book Value Per Share	8.15
Working Capital	217.34M

Cash Flow

In the last 12 months, operating cash flow was -61.19 million and capital expenditures -55.85 million, giving a free cash flow of -117.04 million.

Operating Cash Flow	-61.19M
Capital Expenditures	-55.85M
Free Cash Flow	-117.04M
FCF Per Share	-3.58

Margins

Gross margin is 52.58%, with operating and profit margins of -58.00% and -99.60%.

Gross Margin	52.58%
Operating Margin	-58.00%
Pretax Margin	-79.25%
Profit Margin	-99.60%
EBITDA Margin	-51.12%
EBIT Margin	-58.00%
FCF Margin	n/a

Dividends & Yields

TPEX:6934 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.80%
Shareholder Yield	-6.80%
Earnings Yield	-2.53%
FCF Yield	-2.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6934 has an Altman Z-Score of 12.86 and a Piotroski F-Score of 2.

Altman Z-Score	12.86
Piotroski F-Score	2